High Throughput Screening Technologies for Direct Cyclic AMP Measurement
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2003/04/01
-
Indian UGC (journal)
-
Refrences22
-
Citations74
-
Daniela Gabriel Novartis Pharma AG, Lead Discovery Center, Basel, Switzerland.
-
Magali Vernier Novartis Pharma AG, Lead Discovery Center, Basel, Switzerland.
-
Martin J. Pfeifer Novartis Pharma AG, Lead Discovery Center, Basel, Switzerland.
-
Boris Dasen Novartis Pharma AG, Lead Discovery Center, Basel, Switzerland.
-
Laurent Tenaillon Novartis Pharma AG, Lead Discovery Center, Basel, Switzerland.
-
Rochdi Bouhelal Novartis Pharma AG, Lead Discovery Center, Basel, Switzerland.
Cite
Gabriel, Daniela, et al. “High Throughput Screening Technologies for Direct Cyclic AMP Measurement”. ASSAY and Drug Development Technologies, vol. 1, no. 2, 2003, pp. 291-03, https://doi.org/10.1089/15406580360545107.
Gabriel, D., Vernier, M., Pfeifer, M. J., Dasen, B., Tenaillon, L., & Bouhelal, R. (2003). High Throughput Screening Technologies for Direct Cyclic AMP Measurement. ASSAY and Drug Development Technologies, 1(2), 291-303. https://doi.org/10.1089/15406580360545107
Gabriel D, Vernier M, Pfeifer MJ, Dasen B, Tenaillon L, Bouhelal R. High Throughput Screening Technologies for Direct Cyclic AMP Measurement. ASSAY and Drug Development Technologies. 2003;1(2):291-303.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Peptide therapeutics: current status and future directions
- Exploiting the enhanced permeability and retention effect for tumor targeting
- Natural products in drug discovery
- A new and rapid colorimetric determination of acetylcholinesterase activity
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. | Proceedings of the National Academy of Sciences |
| 230 | 1994 |
| Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. | Methods in Enzymology |
| 1991 | |
| Mammalian Membrane-bound Adenylyl Cyclases | Journal of Biological Chemistry |
| 397 | 1995 |
| 10.1081/RRS-100107427 | ||||
| A Homogeneous Enzyme Fragment Complementation Cyclic AMP Screen for GPCR Agonists | SLAS Discovery |
| 36 | 2002 |
Citations
Citations Analysis
The category
Science: Chemistry: Organic chemistry: Biochemistry 32
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Development of a Sensitive and HTS-Compatible Reporter Gene Assay for Functional Analysis of Human Adenosine A2a Receptors in CHO-K1 Cells and was published in 2004. The most recent citation comes from a 2024 study titled Orphan G protein-coupled receptors: the ongoing search for a home. This article reached its peak citation in 2008, with 10 citations. It has been cited in 52 different journals, 15% of which are open access. Among related journals, the SLAS Discovery cited this research the most, with 8 citations. The chart below illustrates the annual citation trends for this article.